James A. Rickard

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Robin Carhart‐Harris, Mark Bolstridge, James Rucker et al. · The Lancet Psychiatry · 2016 · 1.5K citations · Full text

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

Robin Carhart‐Harris, Mark Bolstridge, Camilla Day et al. · Psychopharmacology · 2017 · 935 citations · Full text

RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis

James A. Rickard, Joanne A. O’Donnell, Joseph M. Evans et al. · Cell · 2014 · 576 citations · Full text

Inflammation, Cytokine, Receptor Tyrosine Kinase +7

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder

Ben Sessa, Laurie Higbed, Steve O’Brien et al. · Journal of Psychopharmacology · 2021 · 116 citations

Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease

Abhinav Vasudevan, Nina Parthasarathy, Danny Con et al. · Alimentary Pharmacology & Therapeutics · 2020 · 24 citations